Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details

Bulletin Express

11/07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1120115825"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120115825\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120115825?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120115825","market":"hk","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-11-07 16:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"復星醫藥","start_time":0,"source_url":"","article_id":"1120115825","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120115825","pubTimestamp":1762503734,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"上海复星医药（集团）股份有限公司(02196)公布2025年第二次临时股东大会详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.\nThe meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}